Dermatological Adverse Effects of Chemotherapeutic Agents: Experience from a Tertiary Centre

    Parvaiz Anwar Rather, Hussain Mir M, Subhash Kaul, Vikas Roshan, Jilu Mathews, B. K. Sharma
    Image of study
    TLDR About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.
    In a study involving 125 oncology patients at a tertiary center, 27 (21.6%) experienced dermatological adverse effects from chemotherapy, with 45 side effects noted in total. Hair loss, specifically anagen and telogen effluvium, was the most common side effect, followed by skin issues like diffuse hyperpigmentation, xerosis, and hand-foot syndrome. Nail discoloration and oral mucositis were also observed. The study found that while these side effects were common, they were not typically severe enough to stop treatment. It highlighted the need for awareness and management of these effects by healthcare professionals to reduce morbidity and improve the quality of life for cancer survivors. The study also acknowledged limitations in pinpointing exact drugs causing certain side effects due to the use of combination chemotherapy regimens.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community Losing ground after 14 months of fin use and 11 months of min

      in Finasteride/Dutasteride  52 upvotes 2 years ago
      A 24-year-old person who is worried about their hair loss after 14 months of taking finasteride and 11 months of minoxidil. Replies to the post suggested sticking with their current regimen, that shedding from one part may not be telogen effluvium, and that shedding is normal with these drugs and they should evaluate in two to three months.

      community Got a microscope camera. Here’s the difference between healthy and miniaturized hair

      in Progress Pictures  492 upvotes 2 years ago
      A user who shared progress pictures of their scalp using a microscope camera, demonstrating the difference between healthy and miniaturized hair. Various explanations for the cause of this were discussed, such as DHT build-up in scalp sebum causing an autoimmune response leading to inflammation and eventual hair loss, with some suggesting a do-it-yourself treatment involving adding ascorbic acid powder to shampoo.

      community Severe accutane TE: will this sort itself out? When?

      in Question  5 upvotes 7 years ago
      A user experienced severe hair loss after stopping Accutane and is concerned about using Minoxidil due to anxiety and doubts about its effectiveness. They are seeking advice on whether the hair loss will resolve on its own and if they should expect recovery soon.

    Similar Research

    5 / 1000+ results
      Hair Disorders

      research Hair Disorders

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.
      Female Adolescent Hair Disorders

      research Female Adolescent Hair Disorders

      20 citations, July 2009 in “Journal of Pediatric and Adolescent Gynecology”
      Quick treatment of hair disorders in teenage girls is important because of the emotional effects.
      Skin Toxicity of Anti-Cancer Therapy

      research Skin Toxicity of Anti-Cancer Therapy

      19 citations, October 2008 in “Journal der Deutschen Dermatologischen Gesellschaft”
      Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.